Glucose‐induced LINC01419 reprograms the glycolytic pathway by recruiting YBX1 to enhance PDK1 mRNA stability in hepatocellular carcinoma
Abstract Metabolic reprogramming provides the necessary energy for the development of malignant tumours and is emerging as a novel tumour treatment strategy. However, the widespread expression of metabolic enzymes in diverse cell types makes the development of specific drugs that target cancer cells...
Saved in:
Main Authors: | Yanfang Liu, Junjiao Song, Qili Shi, Bing Chen, Wenying Qiu, Yizhe Liu, Shenglin Huang, Xianghuo He |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-12-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.70122 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LINC00626 drives tamoxifen resistance in breast cancer cells by interaction with UPF1
by: Hui Yuan, et al.
Published: (2025-01-01) -
The role of the interplay between macrophage glycolytic reprogramming and NLRP3 inflammasome activation in acute lung injury/acute respiratory distress syndrome
by: Lan Luo, et al.
Published: (2024-12-01) -
FTO effects the proliferation, invasion, and glycolytic metabolism of colon cancer by regulating PKM2
by: Kongyan Zhang, et al.
Published: (2025-01-01) -
Long non-coding RNA linc00152 acting as a promising oncogene in cancer progression
by: Danbi Seo, et al.
Published: (2019-11-01) -
LINC02282 promotes DNA methylation of TRIM6 by recruiting DNMTs to inhibit the progression of Parkinson's disease
by: Lu Han, et al.
Published: (2025-03-01)